Literature DB >> 5030579

Purineless death as a link between growth rate and cytotoxicity by methotrexate.

W M Hryniuk.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 5030579

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  10 in total

1.  Role of thymidylate synthetase activity in development of methotrexate cytotoxicity.

Authors:  R G Moran; M Mulkins; C Heidelberger
Journal:  Proc Natl Acad Sci U S A       Date:  1979-11       Impact factor: 11.205

2.  Selective killing of preneoplastic and neoplastic cells by methotrexate with leucovorin.

Authors:  M Chow; H Rubin
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-14       Impact factor: 11.205

3.  Threshold methotrexate concentration for in vivo inhibition of DNA synthesis in normal and tumorous target tissues.

Authors:  B A Chabner; R C Young
Journal:  J Clin Invest       Date:  1973-08       Impact factor: 14.808

4.  Decreased risk of acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation in patients with the 5,10-methylenetetrahydrofolate reductase 677TT genotype.

Authors:  Kyoko Sugimoto; Makoto Murata; Makoto Onizuka; Yoshihiro Inamoto; Seitaro Terakura; Yachiyo Kuwatsuka; Taku Oba; Koichi Miyamura; Yoshihisa Kodera; Tomoki Naoe
Journal:  Int J Hematol       Date:  2008-03-26       Impact factor: 2.490

5.  Thymidine enhancement of methotrexate and 5-fluorouracil toxicity in cultured human colon carcinoma.

Authors:  C Benz; M Choti; L Newcomer; E Cadman
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

6.  Accumulation of DNA strand breaks and methotrexate cytotoxicity.

Authors:  J C Li; E Kaminskas
Journal:  Proc Natl Acad Sci U S A       Date:  1984-09       Impact factor: 11.205

7.  Inhibition of 5-aminoimidazole-4-carboxamide ribotide transformylase, adenosine deaminase and 5'-adenylate deaminase by polyglutamates of methotrexate and oxidized folates and by 5-aminoimidazole-4-carboxamide riboside and ribotide.

Authors:  J E Baggott; W H Vaughn; B B Hudson
Journal:  Biochem J       Date:  1986-05-15       Impact factor: 3.857

8.  Effects of varying the interval between courses of methotrexate on its myelotoxic and anti-leukaemic activities.

Authors:  B Harding; J Culvenor; I C MacLennan
Journal:  Br J Cancer       Date:  1977-01       Impact factor: 7.640

9.  Methotrexate and the need for continued research.

Authors:  F Rosenfelt
Journal:  Yale J Biol Med       Date:  1975-05

10.  Quantification of folate metabolism using transient metabolic flux analysis.

Authors:  Philip M Tedeschi; Nadine Johnson-Farley; Hongxia Lin; Laura M Shelton; Takushi Ooga; Gillian Mackay; Niels Van Den Broek; Joseph R Bertino; Alexei Vazquez
Journal:  Cancer Metab       Date:  2015-05-28
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.